LON:GSK - GlaxoSmithKline Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 1,617 +7.00 (+0.43 %)
(As of 08/17/2018 04:00 PM ET)
Previous CloseGBX 1,617
Today's RangeGBX 1,606 - GBX 1,617.40
52-Week RangeGBX 1,235.20 - GBX 1,724.50
Volume7.34 million shs
Average Volume9.12 million shs
Market Capitalization£65.63 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
GlaxoSmithKline logoGlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; and a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Receive GSK News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange LON
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
SymbolLON:GSK
CUSIPN/A
Phone+44-20-80475000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins9.36%
Return on Equity348.10%
Return on Assets4.98%

Miscellaneous

EmployeesN/A
Outstanding Shares4,920,000,000
Market Cap£65.63 billion

GlaxoSmithKline (LON:GSK) Frequently Asked Questions

What is GlaxoSmithKline's stock symbol?

GlaxoSmithKline trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline announced a dividend on Wednesday, July 25th. Investors of record on Thursday, August 9th will be given a dividend of GBX 19 per share on Thursday, October 11th. This represents a yield of 1.23%. The ex-dividend date of this dividend is Thursday, August 9th. The official announcement can be viewed at this link. View GlaxoSmithKline's Dividend History.

How were GlaxoSmithKline's earnings last quarter?

GlaxoSmithKline plc (LON:GSK) issued its earnings results on Wednesday, April, 25th. The company reported $24.60 earnings per share for the quarter, topping the consensus estimate of $24.30 by $0.30. GlaxoSmithKline had a return on equity of 348.10% and a net margin of 9.36%. View GlaxoSmithKline's Earnings History.

What price target have analysts set for GSK?

23 equities research analysts have issued 12 month target prices for GlaxoSmithKline's stock. Their predictions range from GBX 41.74 to GBX 2,000. On average, they anticipate GlaxoSmithKline's stock price to reach GBX 1,527.03 in the next year. This suggests that the stock has a possible downside of 5.6%. View Analyst Price Targets for GlaxoSmithKline.

What is the consensus analysts' recommendation for GlaxoSmithKline?

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 1 sell rating, 13 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for GlaxoSmithKline.

Who are some of GlaxoSmithKline's key competitors?

Who are GlaxoSmithKline's key executives?

GlaxoSmithKline's management team includes the folowing people:
  • Ms. Emma Walmsley, CEO & Director (Age 48)
  • Mr. Simon P. Dingemans, CFO & Exec. Director (Age 54)
  • Mr. Jack Bailey, Pres of US Pharmaceuticals
  • Ms. Karenann K. Terrell, Chief Digital & Technology Officer (Age 57)
  • Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 55)

Has GlaxoSmithKline been receiving favorable news coverage?

News stories about GSK stock have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. GlaxoSmithKline earned a media and rumor sentiment score of 0.14 on Accern's scale. They also assigned news articles about the company an impact score of 48.42 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View Recent Headlines for GlaxoSmithKline.

How do I buy shares of GlaxoSmithKline?

Shares of GSK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GlaxoSmithKline's stock price today?

One share of GSK stock can currently be purchased for approximately GBX 1,617.

How big of a company is GlaxoSmithKline?

GlaxoSmithKline has a market capitalization of £65.63 billion.

How can I contact GlaxoSmithKline?

GlaxoSmithKline's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The company can be reached via phone at +44-20-80475000.


MarketBeat Community Rating for GlaxoSmithKline (LON GSK)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  761 (Vote Outperform)
Underperform Votes:  1,346 (Vote Underperform)
Total Votes:  2,107
MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Vote "Outperform" if you believe GSK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GSK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.